These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10739170)

  • 1. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis.
    Wadelius M; Stjernberg E; Wiholm BE; Rane A
    Pharmacogenetics; 2000 Feb; 10(1):35-41. PubMed ID: 10739170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease.
    Chen M; Xia B; Chen B; Guo Q; Li J; Ye M; Hu Z
    Can J Gastroenterol; 2007 Mar; 21(3):155-8. PubMed ID: 17377643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
    Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.
    Ricart E; Taylor WR; Loftus EV; O'Kane D; Weinshilboum RM; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Am J Gastroenterol; 2002 Jul; 97(7):1763-8. PubMed ID: 12135032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
    Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
    Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
    Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
    Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
    da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
    World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
    Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
    Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine.
    Ohtani T; Hiroi A; Sakurane M; Furukawa F
    Br J Dermatol; 2003 May; 148(5):1035-9. PubMed ID: 12786839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
    Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
    Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
    Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
    Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.